Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Tadalafil in Duchenne Muscular Dystrophy
jRCT2080222487Phase 3
- Sponsor
- Eli Lilly and Company
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tadalafil in Duchenne muscular dystrophy (DMD) (3 arms), sponsored by Eli Lilly and Company.
02
Drugs
tadalafil
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on jRCT2080222487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222487.